Experience with Generic Pegylated L-asparaginase in Children with Acute Lymphoblastic Leukemia from a Tertiary Care Oncology Center in South India

• Dhaarani Jayaraman,
• Latha M. Sneha,
• Gracelin Jeyarani,
• Alekhya Somayajula,
• Balaji Thiruvengadam Kothandam,
• Julius Xavier Scott,
• A Gadekar

Affiliations

Dhaarani Jayaraman

Division of Pediatric Hemato-Oncology, Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamil Nadu, India

Latha M. Sneha

Division of Pediatric Hemato-Oncology, Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamil Nadu, India

Gracelin Jeyarani

Division of Pediatric Hemato-Oncology, Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamil Nadu, India

Alekhya Somayajula

ORCiD

Department of Pediatrics, Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamil Nadu, India

Balaji Thiruvengadam Kothandam

Division of Pediatric Hemato-Oncology, Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamil Nadu, India

Julius Xavier Scott

Division of Pediatric Hemato-Oncology, Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamil Nadu, India

A Gadekar

Emcure Pharma, Pune, Maharashtra, India